Insights from 2023 ASCO® Annual Meeting


 

ASCO® 2023 Insights: "Updated Results From XPORT-MF-034 - Selinexor + Ruxolitinib in JAKi Treatment-Naïve Patients With Myelofibrosis"

197 views
June 14, 2023
0 Comments
Login to view comments. Click here to Login
Hematology